Renal Phenotype in Mitochondrial Diseases: A Multicenter Study.

Acute kidney injury Mitochondrial DNA Mitochondrial disease Renal manifestations

Journal

Kidney diseases (Basel, Switzerland)
ISSN: 2296-9381
Titre abrégé: Kidney Dis (Basel)
Pays: Switzerland
ID NLM: 101658365

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 13 02 2021
accepted: 23 11 2021
entrez: 9 5 2022
pubmed: 10 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

This study aimed to investigate associations between renal and extrarenal manifestations of mitochondrial diseases and their natural history as well as predictors of renal disease severity and overall disease outcome. The secondary aim was to generate a protocol of presymptomatic assessment and monitoring of renal function in patients with a defined mitochondrial disease. A multicenter, retrospective cohort study was performed by the Mitochondrial Clinical and Research Network (MCRN). Patients of any age with renal manifestations associated with a genetically verified mitochondrial disease were included from 8 expert European centers specializing in mitochondrial diseases: Gothenburg, Oulu, Copenhagen, Bergen, Helsinki, Stockholm, Rotterdam, and Barcelona. Of the 36 patients included, two-thirds had mitochondrial DNA-associated disease. Renal manifestations were the first sign of mitochondrial disease in 19%, and renal involvement was first identified by laboratory tests in 57% of patients. Acute kidney injury occurred in 19% of patients and was the first sign of renal disease in the majority of these. The most common renal manifestation was chronic kidney disease (75% with stage 2 or greater), followed by tubulopathy (44.4%), the latter seen mostly among patients with single large-scale mitochondrial DNA deletions. Acute kidney injury and tubulopathy correlated with worse survival outcome. The most common findings on renal imaging were increased echogenicity and renal dysplasia/hypoplasia. Renal histology revealed focal segmental glomerulosclerosis, nephrocalcinosis, and nephronophthisis. Acute kidney injury is a distinct renal phenotype in patients with mitochondrial disease. Our results highlight the importance to recognize renal disease as a sign of an underlying mitochondrial disease. Acute kidney injury and tubulopathy are 2 distinct indicators of poor survival in patients with mitochondrial diseases.

Identifiants

pubmed: 35527992
doi: 10.1159/000521148
pii: kdd-0008-0148
pmc: PMC9021658
doi:

Types de publication

Journal Article

Langues

eng

Pagination

148-159

Informations de copyright

Copyright © 2022 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Pediatr Nephrol. 2021 Jan;36(1):9-17
pubmed: 31925537
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43
pubmed: 19820136
J Med Genet. 2015 Nov;52(11):779-83
pubmed: 26084283
J Clin Invest. 2011 Oct;121(10):4003-14
pubmed: 21881206
Redox Biol. 2021 Jan;38:101767
pubmed: 33137712
J Clin Invest. 2010 Mar;120(3):791-802
pubmed: 20179356
Pediatr Nephrol. 2013 Mar;28(3):357-61
pubmed: 23233040
Int J Nephrol Renovasc Dis. 2014 Jan 31;7:57-67
pubmed: 24516335
JIMD Rep. 2018;42:61-70
pubmed: 29249003
Am J Kidney Dis. 2002 Jan;39(1):12-23
pubmed: 11774096
JIMD Rep. 2015;23:91-100
pubmed: 25940035
Ann Neurol. 2001 Mar;49(3):377-83
pubmed: 11261513
Genet Med. 2017 Dec;19(12):
pubmed: 28749475
Kidney Int. 2011 Jul;80(1):29-40
pubmed: 21562469
Acta Paediatr. 2009 Jun;98(6):1014-8
pubmed: 19284404
Mol Genet Genomic Med. 2015 Jan;3(1):59-68
pubmed: 25629079
Kidney Int. 1997 Apr;51(4):1000-7
pubmed: 9083263
Pediatr Nephrol. 2005 Sep;20(9):1299-305
pubmed: 15977024
Nat Rev Nephrol. 2017 Oct;13(10):629-646
pubmed: 28804120
Pediatr Nephrol. 2012 Apr;27(4):539-50
pubmed: 21656172
Arch Dis Child Educ Pract Ed. 2017 Feb;102(1):37-43
pubmed: 27647862

Auteurs

Maria Parasyri (M)

Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Per Brandström (P)

Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Johanna Uusimaa (J)

Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit, Research Unit for Pediatrics, Pediatric Neurology, Pediatric Surgery, Child Psychiatry, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Ophthalmology, Otorhinolaryngology, Medical Research Center Oulu (MRC Oulu), University of Oulu, Oulu, Finland.

Elsebet Ostergaard (E)

Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Omar Hikmat (O)

Department of Pediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.

Pirjo Isohanni (P)

Department of Pediatric Neurology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, Helsinki, Finland.

Karin Naess (K)

Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.

I F M de Coo (IFM)

Department Toxicogenomics, Faculty of Health, Medicine and Life Sciences, Graduate School MHeNS, Maastricht University, Maastricht, The Netherlands.

Andrés Nascimento Osorio (A)

Neuromuscular Diseases Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Matti Nuutinen (M)

Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit, Research Unit for Pediatrics, Pediatric Neurology, Pediatric Surgery, Child Psychiatry, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Ophthalmology, Otorhinolaryngology, Medical Research Center Oulu (MRC Oulu), University of Oulu, Oulu, Finland.

Christopher Lindberg (C)

Department of Neurology, Neuromuscular Centre, Sahlgrenska University Hospital, Gothenburg, Sweden.

Laurence A Bindoff (LA)

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Neuro-SysMed, Center of Excellence for Clinical Research in Neurological Diseases, Haukeland University Hospital, Bergen, Norway.

Már Tulinius (M)

Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Niklas Darin (N)

Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Kalliopi Sofou (K)

Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Classifications MeSH